Related Experiment Video
Updated: Jun 19, 2025
13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.5K
Potential New Inflammatory Markers in Bronchiectasis: A Literature Review
Francesco Rocco Bertuccio1,2, Nicola Baio1,2, Simone Montini1,2
1Unit of Respiratory Disease, Cardiothoracic and Vascular Department, IRCCS Policlinico San Matteo, Viale Golgi 19, 27100 Pavia, Italy.
Current Issues in Molecular Biology
|July 26, 2024
Summary
This review summarizes biomarkers and therapeutic targets for bronchiectasis, a complex respiratory condition. Understanding these aspects is crucial for developing effective diagnostic and treatment strategies.
Area of Science:
- Pulmonary Medicine
- Genetics
- Immunology
Background:
- Chronic respiratory disorders like asthma and COPD have identified molecular and inflammatory endotypes, enabling precision medicine.
- Bronchiectasis is characterized by numerous comorbidities and identified underlying causes, with inflammatory endotypes extensively studied.
- Genetic factors influencing disease progression in bronchiectasis are recognized, yet a clear classification remains elusive.
Purpose of the Study:
- To consolidate current knowledge on biomarkers for bronchiectasis.
- To identify actionable therapeutic targets for bronchiectasis.
- To highlight unmet needs in the research and clinical management of bronchiectasis.
Main Methods:
- Literature review of existing studies on bronchiectasis.
- Analysis of identified biomarkers and genetic factors.
- Synthesis of information on inflammatory pathways and comorbidities.
Main Results:
- Summary of current understanding of bronchiectasis biomarkers.
- Identification of potential therapeutic targets based on molecular and inflammatory pathways.
- Outline of knowledge gaps and unmet needs in bronchiectasis research.
Conclusions:
- A clear classification system for bronchiectasis is needed to advance understanding of its natural course.
- Further research into biomarkers and actionable targets is essential for developing precise diagnostic and therapeutic strategies.
- Addressing unmet needs will facilitate the design of effective clinical trials for bronchiectasis.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:20Asthma: Pathogenesis and Management
380
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
380
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:17Drugs Used in Lower Respiratory Disorders: Overview
389
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
389
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
69
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69